Non-invasive prenatal testing now available at The Women's Health Group.
Non-invasive prenatal testing - NIPT analyses cell-free DNA circulating in the pregnant mother’s blood.
It is a new option in prenatal screening for Down syndrome (trisomy 21) and other common chromosomal conditions (trisomies 18 and 13). The pregnancy is not put at risk of miscarriage.
The test identifies in singleton pregnancies more than 99% of fetuses with trisomy 21, 98% of fetuses with trisomy 18, and 80% of fetuses with trisomy 13.